3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Multiple Sclerosis
1
Melanoma
1
Lymphatic Metastasis
1
Lupus Erythematosus, Systemic
1
Lung Neoplasms
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Dermatomyositis
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Bronchial Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Interventions
Carboplatin
6
Radiotherapy
5
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Pemetrexed
3
Biopsy
3
Bevacizumab
3
capmatinib
2
Radiotherapy, Conformal
2
Platinum
2
Paclitaxel
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
CTLA-4 Antigen
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
osimertinib
1
methoxyamine
1
lazertinib
1
fludarabine phosphate
1
durvalumab
1
defactinib
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Platinum Compounds
×
90 days
×
Clear all
No trials found.